10 Best Small-Cap Growth Stocks to Buy Now
On November 4, 2024, Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer unique growth and diversification opportunities.
Urogen Pharma Ltd. (URGN)
Market is closed
News
- 1 - 10
- Next >>
UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by and welcome to the UroGen Pharma Third Quarter 2024 Earnings Call. Please be advised that today's conference is being recorded.
10 Worst Middle East and Africa Stocks To Buy According to Short Sellers
According to the IMF's Middle East and North Africa Economic Update from April 2024, the MENA region is expected to see moderate growth of 2.7% in 2024, up from 1.9% in 2023.
10 Worst ADR Stocks To Buy According to Short Sellers
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank that represents shares of a foreign company. These certificates allow U.S.
UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the 2024 Second Quarter UroGen Pharma Earnings Call. [Operator Instructions] Please advise that today’s conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen. Thank you for standing by. Welcome to the UroGen Pharma First Quarter 2024 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Full Year 2023 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and thank you for standing by, and welcome to the UroGen Pharma Q3 2023 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. And welcome to the UroGen Pharma’s Second Quarter 2023 Earnings Call.
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Q1 2023 Earnings Call. Please be advised that today's conference is being recorded.
- 1 - 10
- Next >>
Billionaire Hedge Funds
